Autoinflammatory Disorders

Gene: MVK

Green List (high evidence)

MVK (mevalonate kinase)
EnsemblGeneIds (GRCh38): ENSG00000110921
EnsemblGeneIds (GRCh37): ENSG00000110921
OMIM: 251170, ClinGen, DECIPHER
MVK is in 17 panels

2 reviews

Bryony Thompson (Royal Melbourne Hospital)

Green List (high evidence)

Well-established gene-disease association. Loss of function is the mechanism of disease. Characterised as an autoinflammatory keratinisation disease.
Sources: Literature
Created: 27 Nov 2025, 10:05 p.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
porokeratosis 3, disseminated superficial actinic type MONDO:0008293

Publications

Variants in this GENE are reported as part of current diagnostic practice

Crystle Lee (Victorian Clinical Genetics Services)

Green List (high evidence)

Well-reported in hyper-IgD and periodic fever syndrome (HIDS) and mevalonic aciduria (MA) patients, which represents a spectrum of clinical phenotypes associated with mevalonate kinase deficiency. Severity and clinical presentation depends on residual enzyme activity, with HIDS being milder than MA.
Created: 22 Jan 2021, 11:40 a.m. | Last Modified: 22 Jan 2021, 11:40 a.m.
Panel Version: 0.98

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Hyper-IgD syndrome (MIM#260920); Mevalonic aciduria (MIM#610377)

Publications

Details

Mode of Inheritance
BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal
Sources
  • Expert Review Green
  • Literature
  • Expert Review Green
  • Melbourne Genomics Health Alliance Immunology Flagship
  • Victorian Clinical Genetics Services
Phenotypes
  • Hyper-IgD syndrome (MIM#260920)
  • Mevalonic aciduria (MIM#610377)
  • porokeratosis 3, disseminated superficial actinic type MONDO:0008293
OMIM
251170
ClinGen
MVK
DECIPHER
MVK
Clinvar variants
Variants in MVK
Penetrance
None
Publications
Panels with this gene

History Filter Activity

27 Nov 2025, Gel status: 3

Set Phenotypes

Bryony Thompson (Royal Melbourne Hospital)

Phenotypes for gene: MVK were changed from Hyper-IgD syndrome (MIM#260920); Mevalonic aciduria (MIM#610377) to Hyper-IgD syndrome (MIM#260920); Mevalonic aciduria (MIM#610377); porokeratosis 3, disseminated superficial actinic type MONDO:0008293

27 Nov 2025, Gel status: 3

Set publications

Bryony Thompson (Royal Melbourne Hospital)

Publications for gene: MVK were set to 29047407; 26409462

27 Nov 2025, Gel status: 3

Set mode of inheritance

Bryony Thompson (Royal Melbourne Hospital)

Mode of inheritance for gene: MVK was changed from BIALLELIC, autosomal or pseudoautosomal to BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal

22 Jan 2021, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: mvk has been classified as Green List (High Evidence).

22 Jan 2021, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: MVK were changed from to Hyper-IgD syndrome (MIM#260920); Mevalonic aciduria (MIM#610377)

22 Jan 2021, Gel status: 3

Set publications

Zornitza Stark (Victorian Clinical Genetics Services)

Publications for gene: MVK were set to

22 Jan 2021, Gel status: 3

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

Mode of inheritance for gene: MVK was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal

18 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

gene: MVK was added gene: MVK was added to Systemic autoinflammatory disease, Periodic fever_MelbourneGenomics_AustralianGenomics_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services,Melbourne Genomics Health Alliance Immunology Flagship Mode of inheritance for gene: MVK was set to Unknown